Shares of Kane Biotech Inc. (CVE:KNE – Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 4000 shares trading hands. The stock had previously closed at C$0.04.
Kane Biotech Stock Up 16.7%
The firm has a market cap of C$5.86 million, a PE ratio of -0.44 and a beta of 0.29. The company has a debt-to-equity ratio of -331.42, a current ratio of 0.80 and a quick ratio of 0.39. The business has a fifty day moving average price of C$0.03 and a two-hundred day moving average price of C$0.04.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Further Reading
- Five stocks we like better than Kane Biotech
- Top Biotech Stocks: Exploring Innovation Opportunities
- Broadcom Stock Crashes 20%—But Wall Street Sees It Soaring to $500
- About the Markup Calculator
- Forget the Chips: 4 Industrial Plays for the AI Rebound
- Most Volatile Stocks, What Investors Need to Know
- MongoDB Could Hit Record Highs—But You’ll Need to Move Fast
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
